Filter News
Area of Research
- (-) Biology and Environment (16)
- Advanced Manufacturing (1)
- Clean Energy (11)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion Energy (1)
- Materials (6)
- Materials for Computing (1)
- National Security (14)
- Neutron Science (8)
- Supercomputing (52)
News Topics
- (-) Machine Learning (8)
- (-) Summit (10)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Artificial Intelligence (9)
- Big Data (9)
- Bioenergy (45)
- Biology (73)
- Biomedical (16)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (11)
- Climate Change (40)
- Composites (5)
- Computer Science (19)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (19)
- Energy Storage (7)
- Environment (89)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Materials (12)
- Materials Science (6)
- Mathematics (3)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (3)
- Net Zero (2)
- Neutron Science (4)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (14)
- Sustainable Energy (30)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
![Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2. Credit: Jason B. Smith/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-07/cells%20200%5B1%5D.png?h=b95f6d72&itok=V2OxqL5l)
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
![Omar Demerdash](/sites/default/files/styles/list_page_thumbnail/public/2020-05/demerdash_crop.jpg?h=8831409f&itok=2J2gUqDr)
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
![Coronavirus graphic](/sites/default/files/styles/list_page_thumbnail/public/2020-04/covid19_jh_0.png?h=d1cb525d&itok=PyngFUZw)
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
![Coronavirus research](/sites/default/files/styles/list_page_thumbnail/public/2020-03/still_original.png?h=d1cb525d&itok=0Md1n6Ct)
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight